Abstract
Ferroptosis is linked to various pathological conditions; however, the specific targets and mechanisms through which traditional Chinese medicine influences ischemic stroke (IS)-induced ferroptosis remain poorly understood. In this study, data from the Gene Expression Omnibus and disease target databases were integrated with ferroptosis-related gene datasets. To identify key molecular targets of Chuanxiong Rhizoma (CX), drug ingredient databases were employed to map CX-related targets. Gene targets and relevant signaling pathways were analyzed using weighted gene co-expression network analysis, protein-protein interaction networks, and pathway enrichment. Machine learning methods (LASSO and SVM) identified intersecting genes, and predictive accuracy was evaluated via ROC analysis. Immune cell infiltration was assessed using CIBERSORT, followed by molecular docking. The JAK-STAT3 pathway was identified as a critical regulatory mechanism, with five key targets (ALOX5, PTGS2, STAT3, G6PD, and HIF1A) central to IS-induced ferroptosis. Elevated infiltration of CD8+ T cells and neutrophils significantly correlated with IS. Active components mandenol and myricanone demonstrated strong binding affinities with these targets. These findings suggest CX could serve as a potential therapeutic approach for IS by modulating ferroptosis and the immune microenvironment.
Introduction
Ischemic stroke (IS) is a major cause of global mortality and long-term disability. Its pathophysiology involves a complex cascade of neuroinflammation and oxidative stress. Recently, ferroptosis—an iron-dependent form of regulated cell death characterized by lipid peroxidation—and the immune microenvironment have emerged as critical factors in post-stroke brain damage. Traditional Chinese Medicine, specifically Chuanxiong Rhizoma (CX), has been used for centuries to treat stroke symptoms, but its precise molecular mechanisms remain largely unknown. This study aims to bridge this gap by identifying the specific targets and pathways through which CX regulates the post-stroke environment.
Methodology
The researchers employed a multi-layered bioinformatic workflow:
- Network Pharmacology: Integration of disease and drug databases to map the interactome between CX components and IS-related genes.
- WGCNA: Identification of gene modules associated with clinical traits of stroke.
- Machine Learning: Utilization of LASSO regression and SVM-RFE to identify robust feature genes.
- Immune Infiltration Analysis: Application of the CIBERSORT algorithm to estimate the proportions of 22 immune cell types in stroke tissue.
- Molecular Docking: Computational simulation of binding affinities between CX's active compounds and identified target proteins.
Results
Differential Gene Expression
Analysis of the GSE16561 dataset revealed significant transcriptomic shifts in IS patients compared to healthy controls. A total of 420 differentially expressed genes (DEGs) were identified, including 96 upregulated and 324 downregulated genes.
Core Targets and Immune Profiling
Through the integration of ferroptosis-related genes and machine learning filters, five core targets were finalized: ALOX5, PTGS2, STAT3, G6PD, and HIF1A. These genes showed high predictive accuracy for stroke (AUC values up to 0.875). Furthermore, immune profiling indicated that IS patients have significantly higher levels of CD8+ T cells and neutrophils, which correlate with the expression of these core targets.
Molecular Docking and Pathway Analysis
The JAK-STAT3 signaling pathway was identified as the central regulatory mechanism. Molecular docking confirmed that CX components, particularly mandenol and myricanone, interact spontaneously and stably with the core targets. For instance, mandenol showed a strong binding affinity to G6PD (-11.4 kJ/mol).
Discussion
The study highlights the intricate link between ferroptosis and the immune response in ischemic stroke. Core targets like ALOX5 and PTGS2 are not only involved in iron-dependent cell death but also significantly correlate with the infiltration of pro-inflammatory immune cells. The JAK-STAT3 pathway acts as a "master switch" that CX modulates to balance pro- and anti-inflammatory effects, potentially mitigating brain damage.
Conclusion and Limitations
This research provides a structural and bioinformatic basis for the therapeutic effects of Chuanxiong Rhizoma in treating ischemic stroke. However, as an in silico study, these findings require further validation through in vivo and in vitro experimental models. Future work should also consider the synergistic effects of CX when used in traditional multi-herb formulas and evaluate the clinical pharmacokinetics of its active compounds.
Summary updated